| Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice … MA Brehm, A Cuthbert, C Yang, DM Miller, P DiIorio, J Laning, ... Clinical Immunology 135 (1), 84-98, 2010 | 333 | 2010 |
| Clinical landscape of oncolytic virus research in 2020 N Macedo, DM Miller, R Haq, HL Kaufman Journal for immunotherapy of cancer 8 (2), 2020 | 308 | 2020 |
| Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human … T Pearson, LD Shultz, D Miller, M King, J Laning, W Fodor, A Cuthbert, ... Clinical and Experimental Immunology 154 (2), 270-284, 2008 | 259 | 2008 |
| Therapy with oncolytic viruses: progress and challenges SZ Shalhout, DM Miller, KS Emerick, HL Kaufman Nature reviews Clinical oncology 20 (3), 160-177, 2023 | 212 | 2023 |
| Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma ND Gross, DM Miller, NI Khushalani, V Divi, ES Ruiz, EJ Lipson, F Meier, ... New England Journal of Medicine 387 (17), 1557-1568, 2022 | 166 | 2022 |
| Somatic driver mutations in melanoma BY Reddy, DM Miller, H Tsao Cancer 123, 2104-2117, 2017 | 156 | 2017 |
| The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. M Al-Khunaizi, CJ Luke, YS Askew, SC Pak, DJ Askew, S Cataltepe, ... Biochemistry 41 (9), 3189-3199, 2002 | 88 | 2002 |
| Immunotherapy for non-melanoma skin cancer SZ Shalhout, KS Emerick, HL Kaufman, DM Miller Current Oncology Reports 23, 1-10, 2021 | 68 | 2021 |
| Targeting TBK1 to overcome resistance to cancer immunotherapy Y Sun, O Revach, S Anderson, EA Kessler, CH Wolfe, A Jenney, CE Mills, ... Nature 615 (7950), 158-167, 2023 | 64 | 2023 |
| High MITF expression is associated with super-enhancers and suppressed by CDK7 inhibition in melanoma P Eliades, BJ Abraham, Z Ji, DM Miller, CL Christensen, N Kwiatkowski, ... Journal of Investigative Dermatology 138 (7), 1582-1590, 2018 | 59 | 2018 |
| Complete pathologic response of metastatic cutaneous squamous cell carcinoma and allograft rejection after treatment with combination immune checkpoint blockade DM Miller, BE Faulkner-Jones, JR Stone, RE Drews JAAD case reports 3 (5), 412-415, 2017 | 54 | 2017 |
| Different mechanisms control peripheral and central tolerance in hematopoietic chimeric mice M Yamazaki, T Pearson, MA Brehm, DM Miller, JA Mangada, TG Markees, ... American Journal of Transplantation 7 (7), 1710-1721, 2007 | 35 | 2007 |
| Cyclin-dependent kinases as therapeutic targets in melanoma. DM Miller, KT Flaherty Pigment Cell and Melanoma Research, 2014 | 33 | 2014 |
| Clinical spectrum of cutaneous melanoma morphology N Klebanov, NS Gunasekera, WM Lin, EB Hawryluk, DM Miller, BY Reddy, ... Journal of the American Academy of Dermatology 80 (1), 178-188. e3, 2019 | 32 | 2019 |
| Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma DM Miller, KT Flaherty, H Tsao Seminars in Cutaneous Medicine and Surgery, 60-67, 2014 | 31 | 2014 |
| Immunotherapy for nonmelanoma skin cancer: facts and hopes SZ Shalhout, HL Kaufman, KS Emerick, DM Miller Clinical Cancer Research 28 (11), 2211-2220, 2022 | 29 | 2022 |
| Inhibition of haspin kinase promotes cell-intrinsic and extrinsic antitumor activity JC Melms, S Vallabhaneni, CE Mills, C Yapp, JY Chen, E Morelli, ... Cancer research 80 (4), 798-810, 2020 | 27 | 2020 |
| Identification and activity of a lower eukaryotic serine proteinase inhibitor (serpin) from Cyanea capillata: analysis of a jellyfish serpin, jellypin. EB Cole, D Miller, D Rometo, RM Greenberg, D Brömme, S Cataltepe, ... Biochemistry 43 (37), 11750-11759, 2004 | 23 | 2004 |
| TdT Expression is a marker of better survival in Merkel cell carcinoma, and expression of B-cell markers is associated with Merkel cell polyomavirus MP Hoang, P Donizy, CL Wu, J Kopczynski, M Pieniazek, DM Miller, J Ryś American Journal of Clinical Pathology 154 (1), 38-47, 2020 | 21 | 2020 |
| Viral infection: a potent barrier to transplantation tolerance. DM Miller, TB Thornley, DL Greiner, AA Rossini Clinical and Developmental Immunology, 2008 | 20 | 2008 |
Sophia Shalhout, PhDAssistant Professor- Harvard Medical School, Mass Eye and Ear在 mgh.harvard.edu 的电子邮件经过验证
